Lintao Wang

5.5k citations
83 papers · 4.2k indexed · h-index 32
Topics
Perovskite Materials and Applications (8 papers)HER2/EGFR in Cancer Research (8 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)
Partner nations
ChinaUnited StatesMacao

In The Last Decade

Lintao Wang

81 papers receiving 4.2k citations

Peers

Lintao Wang
Comparison fields: 5 of 132
  • Molecular Biology 1.5k
  • Electrical and Electronic Engineering 1.3k
  • Materials Chemistry 1.3k
  • Oncology 680
  • Radiology, Nuclear Medicine and Imaging 677
Replace Tian‐Lu Cheng with:
Tian‐Lu Cheng Taiwan
Anna Moore United States
Claudine Kiéda France
Feng Jiang China
Ke Ding China
Pengfei Rong China
Xuewu Liu United States
Elvin Blanco United States
Robert D. Larsen United States
Lintao Wang relative to Tian‐Lu Cheng Taiwan Tian‐Lu Cheng's profile →
Citations per field
00.5×5.4×
Tian‐Lu Cheng · 1×
Citations per year

Countries citing papers authored by Lintao Wang

Since Specialization
Citations

This map shows the geographic impact of Lintao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lintao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lintao Wang more than expected).

Fields of papers citing papers by Lintao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lintao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lintao Wang. The network helps show where Lintao Wang may publish in the future.

Co-authorship network of co-authors of Lintao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lintao Wang. A scholar is included among the top collaborators of Lintao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lintao Wang. Lintao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 1
3 4
4 7
5 1
6 13
7 27
8 1
9 37
10 1
11 262
12 164
13 257
14 13
15 22
16 19
17 124
18 44
19 117
20 35

About Lintao Wang

Lintao Wang is a scholar working on Immunology, Oncology and Molecular Biology, having authored 83 papers that have together received 4.2k indexed citations. Recurring topics across this work include Perovskite Materials and Applications (8 papers), HER2/EGFR in Cancer Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Cancer Research (490 citations), Radiology, Nuclear Medicine and Imaging (677 citations) and Materials Chemistry (1.3k citations). Lintao Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xinjian Li, Zhifeng Shi, Chongxin Shan, Di Wu, David L. Smith, Walter A. Blättler, John M. Lambert, Godfrey Amphlett, Zhuangzhuang Ma and Fei Zhang. Their work appears in journals such as Advanced Materials, Nature Communications and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026